Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks
about
Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injuryOral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injuryClinical trial data in support of changing guidelines in osteoarthritis treatment.Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients.Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirinTopical Treatment with Xiaozheng Zhitong Paste (XZP) Alleviates Bone Destruction and Bone Cancer Pain in a Rat Model of Prostate Cancer-Induced Bone Pain by Modulating the RANKL/RANK/OPG Signaling.Gastrodin protects against chronic inflammatory pain by inhibiting spinal synaptic potentiation.Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety.Evolution of topical NSAIDs in the guidelines for treatment of osteoarthritis in elderly patients.A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain.Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs.Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis.Gallic Acid Enriched Fraction of Phyllanthus emblica Potentiates Indomethacin-Induced Gastric Ulcer Healing via e-NOS-Dependent Pathway.New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.Diclofenac sodium topical solution 1.5% w/w with dimethyl sulfoxide compared with placebo for the treatment of osteoarthritis: pooled safety results.DL-trans-3,4-dihydroxy-1-selenolane (DHS(red)) accelerates healing of indomethacin-induced stomach ulceration in mice.Role of the COX-independent pathways in the ulcer-healing action of epigallocatechin gallate.Synthesis of tert-butyl (substituted benzamido)phenylcarbamate derivatives: anti-inflammatory activity and docking studies.Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD)
P2860
Q24186593-DF328934-87B1-4207-887D-C2A0C08394DAQ24240301-ED748BF7-B345-4F95-B7F6-27A85440DDBEQ30804806-E78A5C7A-71E3-4B17-8674-97ECEA0BC8BEQ33678007-E78C2F8F-1DAF-4971-8537-088039CB7AFFQ33688340-C15EDE72-F949-42B9-AD0F-B6A9100BBB36Q34177563-B8C4EA11-E074-4FBA-9F55-3BEE239A46F7Q35066845-0F141D1F-7EBE-4703-8D2B-AD3015BF0C29Q37419055-314EB8D4-7FDA-4D6B-9265-F8ABE3E6D27CQ37900831-A46F59CE-F31C-4E27-B80D-F69A9CB0D248Q38007564-B3C369CD-3B8D-447A-9825-CCC489280C7AQ38166276-D2BF43E9-0519-475E-A962-18432E5F294BQ40155507-C62870D8-01BB-46CC-B031-F5A9AA14A8ABQ41715750-E5C8F9F6-385A-4021-9D3F-21397D48DBF0Q42322746-0F0736C7-A528-49B1-B4A8-99977C3D89ACQ45019665-143795B1-37F0-4F1D-B870-FDCA73F309F9Q46601875-EAC0C629-2B2D-41D6-85C4-3BB9F92CE8DCQ50505706-F4F9B31D-9820-47A8-8AC7-C379B808410FQ50516048-6BEBAE65-DE2E-447D-B7E9-D171B75EC04BQ53175263-361C02E9-EFEE-4BAE-AF80-D162F4D34414Q57480564-F5FB1E2D-65AF-4BD4-BF86-02F46E847128
P2860
Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks
description
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
scientific article (publication date: October 2006)
@en
vedecký článok (publikovaný 2006-10)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd in 2006-10)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в жовтні 2006
@uk
مقالة علمية (نشرت في أكتوبر 2006)
@ar
name
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@ast
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@en
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@nl
type
label
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@ast
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@en
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@nl
prefLabel
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@ast
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@en
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@nl
P2860
P356
P1476
Primer: managing NSAID-induced ...... tinal and cardiovascular risks
@en
P2093
Francis K L Chan
P2860
P2888
P304
P356
10.1038/NCPGASTHEP0610
P407
P577
2006-10-01T00:00:00Z
P6179
1002023580